Clinical trial
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002188 · Anderson Clinical Research, Industry · Completed
Key facts
| NCT number | NCT00002188 |
|---|---|
| Title | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma |
| Official title | Phase II Evaluation of Oral ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma. |
| Lead sponsor | Anderson Clinical Research, Industry |
| Collaborators | Ligand Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Kaposi, HIV Infections |
| Intervention type | Drug |
| Interventions | Alitretinoin |
| Enrollment | 27 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: